286.53
+3.90
+(1.38%)
At close: 7:02:33 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 8 | 17 | 18 |
| Avg. Estimate | 1.64B | 1.59B | 7.02B | 7.31B |
| Low Estimate | 1.62B | 1.56B | 7B | 7.16B |
| High Estimate | 1.68B | 1.61B | 7.06B | 7.48B |
| Year Ago Sales | 1.57B | 1.51B | 6.63B | 7.02B |
| Sales Growth (year/est) | 4.77% | 4.83% | 5.92% | 4.07% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0KTS.L | -- | -- | -- | -- |
| S&P 500 | 14.20% | 7.78% | 10.97% | 14.16% |
Upgrades & Downgrades
| Initiated | Needham: Buy | 2/12/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 2/7/2025 |
| Maintains | Guggenheim: Buy to Buy | 2/7/2025 |
| Maintains | UBS: Buy to Buy | 2/7/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/7/2025 |
| Maintains | Telsey Advisory Group: Outperform to Outperform | 2/7/2025 |